Tocagen, Inc (TOCA) Covered Calls

You can sell covered calls on Tocagen, Inc to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for TOCA (prices last updated Fri 12:55 PM ET):

Tocagen, Inc (TOCA) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
10.90 +0.40 10.90 10.94 59K - 0.2B
Covered Calls For Tocagen, Inc (TOCA)
Expiration Strike Call Bid Net Debit Return
If Flat
Return If Flat
Mar 15 10 1.55 9.39 6.5% 108%
Apr 18 10 1.60 9.34 7.1% 46.3%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Tocagen Inc., a clinical-stage cancer-selective gene therapy company, focuses on developing and commercializing product candidates designed to activate a patient's immune system against their cancer. Its cancer-selective gene therapy platform is built on retroviral replicating vectors (RRVs), which are designed to deliver therapeutic genes into the DNA of cancer cells. The company's lead product candidate is Toca 511 & Toca FC that is under Phase III clinical trial for recurrent high-grade glioma. It is also developing Toca 511 & Toca FC in a Phase Ib clinical trial for metastatic cancers, including colorectal, pancreatic, breast, lung, and melanoma. In addition, the company is developing other RRVs to deliver genes to cancer cells against validated immunotherapy targets, such as the checkpoint protein PD-L1. Tocagen Inc. was founded in 2007 and is headquartered in San Diego, California.